# Filing Detail

Form ARS - Annual Report to Security Holders:
SEC Accession No. 0000886163-25-000029
Filing Date
2025-04-22
Accepted
2025-04-22 16:12:12
Documents
1
Period of Report
2024-12-31
Effectiveness Date
2025-04-22

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ARS | a10-k_printxclean.pdf | ARS | 2491343
| Complete submission text file | 0000886163-25-000029.txt |  | 3432843

Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-33093 | Film No.: 25857860
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)